Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control

Starting soon

Conditions studied: Atrial Fibrillation, Stroke

In brief

A prospective, non-blinded, multi-center study to assess the impact of early Catheter Ablation (CA) in patients with a new diagnosis of Atrial Fibrillation(AF) at the time of stroke. 100 patients will be enrolled.

Key facts

Study ID

NCT06783868

Run by

Kansas City Heart Rhythm Research Foundation

People needed

100

Starts

2025-10-01

Expected to finish

2027-06-01

Last updated by the study team

2025-08-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ages >18 and able to provide consent.
• Presenting with an acute stroke and new-onset AF
• Modified RANKIN score (mRS) < 6
• Must be able to undergo some form of cardiac monitoring [implantable loop recorder (ILR), electrocardiogram (ECG), Holter monitor] to quantify AF burden

You may not qualify if…

• Patients < 18 years of age
• Unable to provide consent, including mRS = 6.
• Not able to read and write at an 8th-grade level [to complete AFEQT and EQ-5D surveys]
• Positive B-hCG
• Will not follow up with our practice/clinic afterward.
• Cannot tolerate OAC or AAD for any reason.
• Cannot undergo CA for any reason.

Where it is running

• Menorah Medical Center — Overland Park, Kansas, United States
• Kansas City Heart Rhythm Institute - Roe Clinic — Overland Park, Kansas, United States
• Overland Park Regional Medical Center — Overland Park, Kansas, United States
• Centerpoint Medical Center Clinic — Independence, Missouri, United States
• Centerpoint Medical Center — Independence, Missouri, United States
• Research Medical Center Clinic — Kansas City, Missouri, United States
• Research Medical Center — Kansas City, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.